Comparison of brush and biopsy sampling methods of the ileal pouch for assessment of mucosa-associated microbiota of human subjects by Susan M Huse et al.
Huse et al. Microbiome 2014, 2:5
http://www.microbiomejournal.com/content/2/1/5RESEARCH Open AccessComparison of brush and biopsy sampling
methods of the ileal pouch for assessment of
mucosa-associated microbiota of human subjects
Susan M Huse1*, Vincent B Young2,3, Hilary G Morrison4, Dionysios A Antonopoulos5, John Kwon6, Sushila Dalal6,
Rose Arrieta6, Nathaniel A Hubert6, Lici Shen6, Joseph H Vineis4, Jason C Koval5, Mitchell L Sogin4,
Eugene B Chang6 and Laura E Raffals7Abstract
Background: Mucosal biopsy is the most common sampling technique used to assess microbial communities
associated with the intestinal mucosa. Biopsies disrupt the epithelium and can be associated with complications
such as bleeding. Biopsies sample a limited area of the mucosa, which can lead to potential sampling bias. In
contrast to the mucosal biopsy, the mucosal brush technique is less invasive and provides greater mucosal
coverage, and if it can provide equivalent microbial community data, it would be preferable to mucosal biopsies.
Results: We compared microbial samples collected from the intestinal mucosa using either a cytology brush or
mucosal biopsy forceps. We collected paired samples from patients with ulcerative colitis (UC) who had previously
undergone colectomy and ileal pouch anal anastomosis (IPAA), and profiled the microbial communities of the
samples by sequencing V4-V6 or V4-V5 16S rRNA-encoding gene amplicons. Comparisons of 177 taxa in 16
brush-biopsy sample pairs had a mean R2 of 0.94. We found no taxa that varied significantly between the brush
and biopsy samples after adjusting for multiple comparisons (false discovery rate ≤0.05). We also tested the
reproducibility of DNA amplification and sequencing in 25 replicate pairs and found negligible variation
(mean R2 = 0.99). A qPCR analysis of the two methods showed that the relative yields of bacterial DNA to human
DNA were several-fold higher in the brush samples than in the biopsies.
Conclusions: Mucosal brushing is preferred to mucosal biopsy for sampling the epithelial-associated microbiota.
Although both techniques provide similar assessments of the microbial community composition, the brush
sampling method has relatively more bacterial to host DNA, covers a larger surface area, and is less traumatic to
the epithelium than the mucosal biopsy.
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Microbiome methodsBackground
In recent years, clinical research has highlighted the im-
portant role of commensal gut microbes in human health.
The gut microbiota not only plays a major role in health,
but also in the etiopathogenesis of complex immune disor-
ders such as inflammatory bowel diseases, type I diabetes,
metabolic disorders, irritable bowel syndrome, and cancer* Correspondence: susan_huse@brown.edu
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unless otherwise stated.[1-8]. Most studies of human gut microbial communities
rely on the non-invasive collection of stool samples. While
this has proven informative, analyses of the fecal microbiota
may miss opportunities to understand the role of the
mucosa-associated microbes, which live in close proximity
to the intestinal epithelium and may not be adequately rep-
resented in the luminal (fecal) samples. The mucosa-
associated microbes may also play a more important role in
diseases such as inflammatory bowel disease (IBD), where
direct interactions likely occur between the host immune
system and the microbes living in the mucus layer of thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mucosa-associated microbiota has not yet been defined.
Studies of the mucosa-associated microbes in the gut typ-
ically make use of mucosal biopsies obtained during
endoscopic procedures. While individual biopsies present
minimal risk, repeated biopsies, particularly in an individual
with underlying bowel inflammation, can lead to bleeding
and infection. Additionally, mucosal biopsies include only a
small surface area and can therefore lead to sampling bias,
especially for rare taxa, if the bacterial populations have a
patchy distribution. Mucosal biopsies frequently contain a
large proportion of contaminating host DNA, which com-
plicates metagenomic and other molecular analyses.
In contrast, mucosal brushing reduces the risks associ-
ated with mucosal biopsies and provides a more repre-
sentative sampling of the mucosal surface. Mucosal
brushings obtained during an endoscopic procedure are
less invasive than mucosal biopsies. They have the ad-
vantage of covering a larger surface area of the bowel
than a biopsy. Furthermore, brushings do not remove at-
tached epithelium and subsequently should have a
smaller proportion of host cells.
We prospectively followed patients with a history of
ulcerative colitis (UC) who had undergone total procto-
colectomy with ileal pouch anal anastomosis (IPAA). In
an effort to identify an accurate but less invasive sam-
pling method of the mucosal-associated microbiota, we
sought to determine whether mucosal brushings are a
comparable sampling method to the mucosal biopsy. To
test whether the two techniques provide equivalent sam-
pling of the mucosa-associated microbiota, we per-
formed paired samplings using both brush and biopsy
sampling in a subset of subjects of our larger IPAA pa-
tient cohort. To understand the variation due to sam-
pling technique as opposed to variation inherent in the
DNA amplification and sequencing, we also evaluated
the reproducibility of technical replicates by independ-
ently reamplifying and resequencing 25 samples.
Methods
Sample collection
We collected 16 paired mucosal biopsies and mucosal
brushings from four patients with UC enrolled in a lon-
gitudinal study that explores the role of the enteric
microbiota in pouchitis. All patients underwent colec-
tomy and IPAA as part of their treatment. Samples from
the ileal pouch were collected prior to closure of the di-
verting ileostomy and at nine additional time points over
the course of 2 years following reinstitution of the fecal
stream as fully described by Young et al. [9]. These oc-
curred at 14, 16, 20, and 24 months post-surgery for pa-
tient 200; 12, 16, and 17 months for patient 206; 8, 12,
16, 18, and 20 months for patient 207; and 4, 12, 17, and
20 months for patient 210. All patients gave writteninformed consent to participate in this research study,
with the understanding that the results were to be pub-
lished. The Institutional Review Board of the University
of Chicago Medical Center approved the study protocol.
None of the patients underwent any form of bowel
preparation or lavage, which can distort the luminal and
mucosa-associated complement of microbiota. In all
cases, the mucosal brushings were obtained prior to bi-
opsies to prevent contamination of the brush samples
with blood. Mucosal brushings were performed using
Cook Medical Endoscopy Cytology Brushes (Cook Med-
ical no.: G22108). The cytology brush was advanced
through the colonoscope channel. Brushings were done
using broad or long strokes, applying gentle pressure to
the pouch mucosa. Sampling of a larger surface area of
the ileal pouch epithelium was therefore possible with
each brushing, and effort was made to sample areas of
the ileal pouch with some stool adherent to the pouch
wall to ensure that the passage of harder stool had not
scraped away mucosa-adherent bacteria. The brush was
then retracted into its sterile sheath prior to withdrawal
through the colonoscope channel. Mucosal biopsies
were taken using standard biopsy forceps. Samples were
placed on dry ice and then stored at −80°C until
processing.
Amplicon library construction and sequencing
During the course of the research project, we shifted
from using the Roche GS FLX Titanium sequencing
platform (454) to the Illumina MiSeq platform. Because
the MiSeq read length is shorter than that of the GS
FLX, we targeted a smaller 16S region to optimize read
quality. Samples from patient 207 at 20 months and pa-
tient 210 at 12, 17, and 20 months were sequenced using
Illumina. We sequenced all other samples using the GS
FLX. We have included both sets of data to demonstrate
that the brush and biopsy results are similar with both
technologies.
Amplicon libraries for GS FLX Titanium sequencing
span the V4-V6 16S rRNA region (sequenced from the
1046R towards 518 F primer, ~546 nt). Illumina MiSeq
amplicons span the V4-V5 16S rRNA region (paired-end
sequenced between 518 F and 926R, ~408 nt). The 16S-
specific primers and the sequencing adaptors are shown
in Additional file 1: Table S1. Primers for GS FLX se-
quencing contain the GS FLX Titanium amplicon adap-
tors, a forward or reverse 16S-specific primer, and a 5-nt
multiplexing identifier (MID) between the sequencing
primer binding site and the 16S-specific region. Primers
for Illumina sequencing contain the bridge adaptors ne-
cessary for clustering, sequencing primer binding sites,
forward or reverse 16S-specific primer, and an in-line
MID (forward primer) or index that is sequenced in a
separate indexing read (reverse primer). We use a
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braries. The 16S-specific primers contain degenerate
sites or, in the case of 926R, represent a combination of
three distinct oligonucleotides in order to capture broad
eubacterial diversity.
Our GS FLX amplification and sequencing protocols
are described in Marteinsson et al. [10] and Young et al.
[9]. The V4-V5 amplicons for Illumina sequencing were
generated using a two-step amplification procedure. The
first step reaction mix contained 1× Platinum HiFi Taq
polymerase buffer, 2 mM MgSO4, 0.2 mM dNTPs,
0.4 μM of the forward and reverse 16S-only primers
(Additional file 1: Table S1), 10–30 ng genomic DNA,
and 10 units of Platinum HiFi Taq polymerase (Life
Technologies, Carlsbad CA) in a volume of 100 μl. This
mix was divided into three replicate reactions before
cycling. Cycling conditions were: an initial 94°C, 3-min
denaturation step; 25 cycles of 94°C for 30 s, 60°C for
45 s, and 72°C for 60 s; and a final 2-min extension at
72°C. The triplicate PCR reactions were pooled after
amplification and purified using Ampure XP (Beckman
Coulter, Indianapolis IN) in a 1:1 volume ratio according
to the manufacturer’s protocol. The purified PCR prod-
ucts were eluted in 20 μl of Qiagen buffer EB (Qiagen,
Valencia CA); 4 μl of the eluate served as template for
the second step. Reaction components were the same as
in the first step except that the amount of Taq was re-
duced to 2 units and a reaction volume of 25 μl was
used. The entire 25 μl volume was amplified as above
for five cycles. PCR products were size-selected using
a 1:1 ratio of Ampure XP to sample to exclude primer-
dimer products. Libraries were quantitated using
PicoGreen QuantIt (Life Technologies, Carlsbad CA)
and pooled in equimolar amounts. The final pool was
quantitated using the KAPA library quantification
protocol (Kapa Biosystems, Boston MA). Libraries were
sequenced on an Illumina Miseq 250-cycle paired-end
run. The combination of CASAVA 1.8.2 to identify reads
by index and a custom Python script that resolved
barcodes demultiplexed the data sets.
Technical replicate pairs were sequenced using the
Roche GS-FLX Titanium protocol as described above.
We tested the reproducibility of our amplification and
sequencing early in the experiment, and the samples are
from patient 200 (initial visit, 2, 4, and 8 weeks), patient
206 (initial visit, 3, 5, and 8 weeks), patient 207 (initial
visit, 2, 4, and 8 weeks), and patient 210 (initial visit, 3
and 5 weeks). All of the samples from patients 206 and
207 and the first two samples from patient 210 were du-
plicated biopsies (sampled twice on the same visit), and
we used both in the technical replication experiment, for
a total of 25 technical replicate pairs (4 from patient
200, 8 from patient 206, 8 from patient 207, and 5 from
patient 210).qPCR of bacterial and human DNA
Quantitative PCR (qPCR) was used to assay the quantity of
bacterial rRNA operons in the samples normalized to a
single-copy host gene (TNF-α). Real-time qPCR was per-
formed on a Roche Lightcycler 480 using LightCycler 480
96-well plates (Roche) covered with LightCycler 480 sealing
foil (Roche). Each 20-μl reaction was performed in triplicate
and contained 10 μl 2× SYBR Green PCR Master Mix
(Roche), 1 μl of each primer (10 μM concentration, 0.5 μM
final), 1 μl template DNA, and 7 μl of Hypure Molecular
Biology grade water (Thermo Scientific). For detection of
the bacterial signal, we used the primer-probe combination
of: forward primer (5’-TCCTACGGGAGGCAGCAGT-3’),
reverse primer (5’-GGACTACCAGGGTATCTAATCCT
GTT-3’), and probe (5’-[6-carboxyfluorescein]-CGTAT
TACCGCGGCTGCTGGCAC-[6-carboxytetramethylrhoda
mine]-3’) [11]. The amplification reaction conditions were
95°C for 10 min and 40 cycles of 95°C for 15 s and
60°C for 1 min. Detection of the host signal used a primer-
probe combination of forward primer (TNFa_hu_se;
5’- AGGAACAGCACAGGCCTTAGTG-3’), reverse primer
(TNFa_hu_as; 5’- AAGACCCCTCCCAGATAGATGG-3’),
and probe (TNFa_hu_probe; 5_-Cy5-CCAGGATGTGGA
GAGTGAACCGACATG-Iowa Black RQ-3_) [12]. Amplifi-
cation of the host signal began with incubation at 95°C for
10 min, followed by 45 cycles of 95°C for 20 s and 64°C for
30 s. All oligonucleotides used were ordered from
Integrated DNA Technologies.
Amplification product size was verified using agarose
gel electrophoresis, and quantification of product copy
numbers was inferred from a dilution series of purified
plasmids containing a representative target (Escherichia
coli for the bacterial 16S rRNA encoding gene and hu-
man TNFα). Templates for these positive controls were
amplified from E. coli TOP10 using 8F and 1492R
primers [13] and human genomic DNA using TNFα_-
hu_se and TNFα_hu_as primers [12], respectively.
Amplicons were then cloned using the TOPO TA clon-
ing kit (pCR4-TOPO vector; Invitrogen) and sequences
verified using Sanger sequencing. Purified plasmids were
then quantified using the Qubit (Invitrogen), and stan-
dards ranging in concentration from 109–101 plasmid
copies/μl were prepared. These standards were run in
parallel with our samples, and a standard curve was gen-
erated to assess target copies within each sample.
Data analysis
Quality filtering for pyrosequencing data retained reads
that (1) had exact matches to the MID and proximal pri-
mer (1046R), (2) contained no ambiguous bases (Ns),
and (3) had average quality scores greater than 30 [14].
Because the length of the amplified regions exceeded the
high-quality read length capability of the GS FLX, our
informatics pipeline truncated all reads at a known
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and V5 regions, TGGGCGTAAAG, or discarded reads
that lacked the anchor sequence. The Illumina MiSeq
reads were merged and quality filtered using custom
Python scripts that allowed no more than three mis-
matches in the overlap region of paired end reads. This
process is a modification of the methods described in
Eren et al. [15] (code available at https://github.com/
meren/illumina-utils). UCHIME [16] removed chimeras
using both the reference mode against Gold reference
set [17] and the de novo mode. We assigned taxonomy
using GAST [18] to compare reads against the SILVA
16S reference database [19] including, whenever
possible, assignments to the genus level. We uploaded
the trimmed and quality-filtered sequences to the
Visualization and Analysis of Microbial Population
Structures website (VAMPS) (http://vamps.mbl.edu) [20]
where they are publicly available under projects
VBY_BRBI_Bv6v4 and VBY_BRBI_Bv4v5. Simple relative
abundance, mean, standard deviation, and Chao alpha
diversity [21] calculations were performed in R [22,23].
Alpha diversity was calculated after subsampling all data
sets to the minimum number of reads (2,023), so that
estimates could be compared.
We define technical replicates as two independent
PCR amplifications and subsequent sequencing from the
same DNA extraction of a specific sample. We define
brush-biopsy pairs as a biopsy sample and a brush sam-
ple taken from the ileal pouch of the same patient at the
same visit.
To assess the potential effect of sampling bias on de-
tection of taxa and determination of relative abundances
using the brush and biopsy techniques, we performed
both the paired Student’s t-test (parametric) and
Wilcoxon rank sum test (non-parametric) in R (t.test
and wilcox.test, paired = TRUE for both) comparing the
brush data sets to the biopsy data sets. Although non-
parametric tests are often considered more robust, mi-
crobial communities typically contain a long tail of low
abundance taxa, and small variations in abundances can
cause a large shift in rank, possibly leading to incorrect
estimates of the number of taxa that differ significantly
between data sets. We corrected for multiple experi-
ments (false discovery rate or q-value) using the
Benjamini-Hochberg algorithm (p.adjust in R). We con-
sidered taxonomic differences to be statistically signifi-
cant if their q-values were less than or equal to 0.05.
As an additional check on differences between the
brush and biopsy techniques, we also used the LDA Ef-
fect Size method (LEfSe) [24]. LEfSe is a microbial com-
munity biomarker tool that identifies features (taxa) that
differ between classes of samples (brush vs. biopsy).
LEfSe uses the non-parametric Kruskal-Wallis rank-sum
test. While we believe that statistics explicitly assessingsample pairs are more sensitive to changes within
pairs when using diverse samples such as stool, LEfSe
is used frequently in microbial analyses. To test
whether the selection of sampling method affects
common downstream analyses, we included an LEfSe
analysis. We uploaded the abundance matrix of all
taxa with a mean count greater than five reads. We
used per-sample normalization, default values of alpha
(= 0.05) and the threshold log LDA score (= 2). We
ran the analysis using both stringency levels (“all against
all” and “one against all”).
To assess overall pairwise similarity, we compared the
number of sequences in one sample assigned to each
taxon with the number of sequences assigned to the
same taxon in the other sample. We made this compari-
son using the Pearson product–moment correlation co-
efficient (R2) between the two samples of each pair for
all pair sets (technical replicates and brush-biopsy pairs)
using the cor function in R [22,23]. Taxa present in one
data set of a pair and not in the other are represented in
the latter by an abundance value of 0. Taxa not present
in either sample are not included in the analysis. We
subsampled (randomly, without replacement) the larger
data set in each pair to match the number of reads in
the smaller data set using a custom perl script (ran-
dom_mtx) so that each pair represented two data sets
with the same number of reads. Unequal sampling depth
biases the Pearson correlation because of the presence of
many low abundance taxa detected in the larger data set
but not detected in the smaller one. We prefer Pearson’s
correlation to Spearman’s for stringency, because it tests
not simply whether the rank order of taxa abundances is
similar (Spearman), but also that the relative abundance
values (Pearson) of taxa data sets are similar. Most mi-
crobial community analyses are based on the relative
abundances of taxa, not their rank.
We carried out a principal coordinates analysis (PCoA)
and generated a UPGMA dendrogram for the brush-
biopsy pairs based on the Morisita-Horn distance metric
using VAMPS to demonstrate how the brush and biopsy
pairs cluster in the larger set of samples. Both of these
clustering methods are commonly used for microbiome
analyses as reported in the current literature. We used
the complete data sets for community distance compari-
sons because the Morisita-Horn community distance
metric compensates for differences in sampling depth,
precluding the need to randomly subsample sequences
to the same depth.
The relative proportion of bacterial to human DNA
was calculated by first generating a standard curve rela-
tive to the dilution series performed during qPCR in
order to correlate fluorescence with copy number. The
equation for the standard curve was then applied to the


























Figure 1 Correlation of sample pairs. Pearson product–moment
correlation values for two sets of paired samples: brush vs. biopsy
method sample pairs and paired technical replicates of the DNA
amplification and sequencing process. Excepting one outlier,
brush-biopsy pairs correlated exclusively above 0.87, with a mean R2
of 0.94. All technical replicate pairs correlated above 0.93 with a
mean R2 of 0.99.
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TNF-α encoding gene) per reaction and per ng of tem-
plate. The ratio of 16S rRNA-based copy number rela-
tive to TNF-α copy number per ng of DNA was then
used to infer gross fold differences between brush and
biopsy samples for each of the samples. These values
were then averaged by patient so that the standard devi-
ations could be calculated.
Results and discussion
Overview of the pouch microbiota
Following reinstitution of the fecal stream through the
ileal pouch, there is an evolution of the microbiota as
the community begins to take on features more similar
to those of the healthy colonic microbial community [9].
In the present study, we sampled the pouch microbiota
at different time points at various states of health and
disease (inflammation of the pouch). The ten most
abundant taxa across all samples include (in order): Bac-
teroides, Lachnospiraceae (genus unknown), Clostridium,
Enterobacteriaceae (genus unknown), Blautia, Rose-
buria, Epulopiscium, Peptostreptococcaceae (genus un-
known), Acidaminococcus and Streptococcus. Together,
the six most abundant taxa represent an average of 70%
(± 10%) of taxa across the samples, and the top ten
together represent 82 ± 3.5%. The variation of microbial
composition is quite large across the samples, with
Bacteroides, the most abundant taxon, ranging from 0 to
60% (25 ± 23%) and Lachnospiraceae ranging from
9.5%-34% (20 ± 8%). Intriguingly, although the standard
deviation of the abundance of the top ten taxa ranges
from 3.2 to 23, the coefficients of variation (standard
deviation/mean) are all equal to 16, implying a similar
relative variation for all of these taxa. The Chao alpha
diversity estimates for these samples averaged 39
(range: 25–96), but included a very broad range of
confidence limits from 22 to 410, implying that the
minimum sample size of 2,023 is not adequately character-
izing many of these communities. Fortunately, all but 3 of
the 32 data sets had more than 5,000 high-quality reads.
Taxon-specific statistical analyses
None of the taxa had a false discovery rate of q ≤ 0.05
with either Student’s t-test or the Wilcoxon rank sum
test; hence, no taxa exhibit statistically significant
variation between the two methods. We used LEfSe
to confirm our results. LEfSe identified no discrimina-
tive taxa between brush and biopsy samples.
Correlation analysis for sample pairs
The 16 brush-biopsy pairs (samples using both tech-
niques from the same patient on the same visit) had
a mean genus-level Pearson R2 of 0.94 ± 0.04, with all
but two sample pairs having an R2 greater than 0.90(Figure 1). This demonstrates that the taxon-by-taxon
abundances are highly reproducible between the two
methods. The 25 technical replicate pairs (same DNA
extraction, but independent PCR amplification and se-
quencing) had a mean Pearson R2 of 0.99 ± 0.01, with
all pairs having an R2 > 0.93, demonstrating excellent
reproducibility of the rRNA gene amplification and of
the DNA sequencing across the Roche GS FLX Titan-
ium and Illumina MiSeq platforms. Sample 206–
16 months is an outlier in our analysis (R2 = 0.66).
There could be many reasons for this, including het-
erogeneity of the pouch, imperfect sample collection,
or minor contamination of the sample during pro-
cessing. Unfortunately, we did not have sufficient
DNA remaining to repeat the amplification and se-
quencing and verify the result.
Community distance metrics
The UPGMA clustering dendrogram analysis of the
brush-biopsy pairs shows that 3 of the 16 pairs (206–
16 months, 207–20 months, and 210–20 months) did
not form a clade together as would be expected. This
would suggest differences between sampling methods
in these samples. Based on our taxonomic evaluation,
however, this does not represent a consistent bias be-
tween the two methods. If these three pairs were ex-
cluded, all other sample pairs did appear in the same
clade (Figure 2A). The dendrogram contains many
short inter-pair branch lengths for patients 207 and
210, implying that pouch microbiota at these patient
visits were very similar.
We illustrate these same results in a PCoA plot
(Figure 2B). The average pairwise distance of brush-
A B
Figure 2 Clustering of sample pairs. UPGMA dendrogram (A) and principle coordinate analysis (PCoA) (B) of the brush-biopsy sampling pairs.
Results show the close clustering of samples from the same brush-biopsy pairs, as evidenced by the short branch lengths in the dendrograms
and the close proximity of the points in the PCoA.
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16 (distance = 0.34). The samples of pair 206–12 ap-
pear different, but their pairwise distance is only 0.16.
While several of the samples do not appear to cluster
exclusively by pair, these data represent multiple visits
from only four patients who have recently undergone
a similar major surgery, and their pouch microbiome
is quite consistent across many of the visits. In other
words, the samples are so similar that despite theFigure 3 Comparison of DNA yields. Comparison of bacterial and huma
the averaged brush and the averaged biopsy samples for each patient. Bru
human TNF-α.reproducibility of the sampling methods, multiple
pairs cluster together. Overall, the biopsy and brush
methods fall into the same group of samples. Dendro-
gram and PCoA plots do not provide information
about specific taxa that might differ across the sam-
pling methods, but they are commonly used in micro-
biome analyses. Our combined results demonstrate
that brush and biopsy sampling methods provide
similar sample clustering results.n host DNA yields from brush and biopsy methods. The bars represent
sh samples show a much larger ratio of bacterial 16S DNA to
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While the taxa represented by the two sampling
methods are similar, brush sampling yields an improved
ratio of bacterial DNA to human DNA (Figure 3). The
average fold difference between brush and biopsy sam-
ples for the bacterial signal (normalized to human) was
21.2-fold higher for patient 200 and even greater for the
other three patients: 100.7-fold for patient 206, 99.7-fold
for patient 207, and 441.3-fold for patient 210. The large
variation in ratio of bacterial to human DNA is likely
caused by a variation in the fecal matter, which can
sometimes be very watery and thin, dominated by
mucus, or can be more characteristic of a full stool sam-
ple with a large bacterial load.
Nonetheless, the favorable bacterial to human DNA
ratio is a boon for metagenomic and other analyses that
require separating host from microbiome sequences and
for low biomass samples where DNA extraction and
amplification have very low yields.
Conclusions
These data show that mucosal brushings and mucosal
biopsies provide comparable results for sampling the
mucosa-associated microbiota in the pouch of UC pa-
tients. Paired samples showed a 0.94 Pearson product–
moment correlation (R2). We detected no statistically
significant taxonomic differences attributable to the
sampling method. The impact of the sampling technique
on the patient, however, is quite different. Repeated bi-
opsies traumatize the epithelium, whereas mucosal
brushings are less invasive and carry minimal to no risk,
an attractive feature to both institutional review boards
and patients. Brush samples also offer clear advantages
in providing a much higher ratio of bacterial DNA to
host DNA and sampling from a much larger surface
area, which should provide better representation of rare
taxa and of a heterogeneous mucosal layer, as can occur
in IBD patients.
Our study also demonstrates that technical replicates
(independent rRNA gene amplification and sequencing
from the same DNA extraction) correlate nearly per-
fectly (R2 = 0.99).
Our samples derive from the small bowel epithelium
of the ileal pouch. While most samples for microbial
analysis come from the colon, our prior work has shown
that the microbial community of the pouch in healthy
individuals is similar to that of the healthy colon [9]. We
believe our findings will be applicable to studies of the
small bowel and the colon, but additional research is re-
quired to verify this.
Although great progress has been made in understand-
ing the role of the microbiota in health and disease, lon-
gitudinal studies with repeated sampling of microbial
communities over time increase the ability to identifypotential causal relationships. Targeted sampling of the
mucosa-associated microbiota has relied primarily on bi-
opsies taken during endoscopy. Looking forward, our re-
sults may help with the innovation of alternative
sampling methods of the mucosa-associated micro-
biome. Repeated endoscopy is cost prohibitive and inva-
sive. An anoscope with a cytology brush, on the other
hand, can easily sample the mucosa-associated micro-
biome during an office visit. As was the case with our
flexible sigmoidoscopic exams, there would be no need
for bowel preparation, which can distort the natural
complement of mucosa-associated microbiota.
Availability of supporting data
The trimmed and quality-filtered sequences have been
uploaded to the Visualization and Analysis of Microbial
Population Structures website (VAMPS) (http://vamps.
mbl.edu) [20] where they are publicly available under
project names VBY_BRBI_Bv6v4 and VBY_BRBI_Bv4v5.
Raw sequences are also available through the NCBI, Bio-
Project ID PRJNA46315. Note that the sample names in-
cluded in this publication have been modified to reflect
the number of months the patients has been included in
the study. The archived sample names are based on visit
number. The sample numbers for patient 200, months
14, 16, 20, 24 are 200_14, 200_8, 200_9, 200_10. Sample
numbers for patient 206 months 12, 16, 17 are 206_7,
206_8, 206_12. Sample numbers for patient 207 months
8, 12, 16, 18, 20 are 207_6, 207_7, 207_8, 207_12, 207_9.
Sample numbers for patient 210, months 4, 12, 17, and
20 are 210_5, 210_7, 210_8, and 210_9. The letters “E”
and “F” designate biopsy samples, and “GG” designates
brush samples.
Additional file
Additional file 1: Table S1. Amplification primer sequences for both
the Roche GS FLX Titanium and Illumina MiSeq platforms and for
amplification of both the V4-V6 (454) and V4-V5 (MiSeq) regions of the
SSU rRNA (16S) gene. Table S2. Sequencing read counts for all
brush-biopsy sample pairs including the total number of reads, the
number of reads identified as low quality, the number of reads identified
as chimeras, and the total number of remaining high-quality sequencing
reads used for analysis.
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